Although a possible neurotransmitter role was claimed, i.e., for prostaglandins [144,145,146,147] and somatostatin [148,149,150], this was not combined with the cytoprotective effect and possible pleiotropic effect (organoprotection)
James SJ, Cutler P, Melnyk S, et al
Source: Polaris Market Research Analysis To Understand More About this Research:Download Sample Report Why GLP-1 Matters
Starting Treatment With Confidence Palpitations are a real and common experience on GLP-1 medications
Several next-generation compounds are progressing through clinical development that may offer improved efficacy, better tolerability, or lower production costs